Claes Wahlestedt

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Claes Wahlestedt is a Swedish-American biomedical researcher and entrepreneur. He is a professor at the University of Miami.

Claes Wahlestedt is a Swedish-American biomedical researcher and entrepreneur. He is a professor at the University of Miami.

Research

He is the inventor of the so-called AntagoNAT oligonucleotide technology, which allows for upregulation of genes in genetic and other disorders. A number of small molecule drugs have also been discovered by or under Wahlestedt's direction.

Career

He was a founding faculty member and director of neuroscience research at the Florida campus of The Scripps Research Institute (2005-20111). In recent years he has co-founded several biotechnology companies, including CuRNA Inc., which was acquired by OPKO Health in 2011, Epigenetix Inc. and Jupiter Orphan Therapeutics.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1369946904 under CC BY-SA 4.0; modifications have been made.

References

  1. ↩Wikipedia “Claes Wahlestedt” revision 1369946904 · retrieved 2026-10-20 date of foundation (×1) · confidence 0.95 revision URL